Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$4.13 -0.04 (-0.96%)
As of: Oct 21, 2026 · 10:33 AM EDT

Vanda Pharmaceuticals (VNDA) Acquisitions (2023 - 2024)

Updated

Analysis

Vanda Pharmaceuticals (VNDA) Acquisitions (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.80 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 614.95 Bn 533.47 Bn 17.26 Bn -17.24 Bn
3 AbbVie 505.05 Bn 478.16 Bn 12.70 Bn -
4 Merck 368.08 Bn 322.46 Bn 12.21 Bn -
5 Novartis Ag 298.32 Bn 262.31 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.58 Bn 235.26 Bn 12.86 Bn -
7 Amgen 236.05 Bn 191.45 Bn 7.24 Bn -
8 Gilead Sciences 190.61 Bn 164.80 Bn 6.22 Bn 11.21 Bn
9 Pfizer 169.86 Bn 116.50 Bn 10.94 Bn -
10 Vanda Pharmaceuticals 248.43 Mn -681.50 Mn 46.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 1.52 Mn
Mar 31, 2024 2.71 Mn
Dec 31, 2023 100.67 Mn
API Access

Vanda Pharmaceuticals Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=VNDA&period=max&api_key=YOUR_API_KEY